Glenmark Pharmaceuticals has informed about a Press Release dated December 21, 2015 titled ‘Glenmark Pharmaceuticals announces the settlement of Paragraph IV litigation with Forest Laboratories’.
The above information is a part of company’s filings submitted to BSE.